Oncology Central

The next generation of novel therapies for the management of relapsed multiple myeloma

0

The advent of various novel therapies such as immunomodulators and proteasome inhibitors has transformed the treatment paradigm for patients with multiple myeloma (MM). As a result, the overall survival has improved dramatically over the last decade. Despite these advances, MM remains mostly incurable and most patients experience disease relapse after enjoying a period of disease control or remission.

To view restricted content, please:
Share:

Leave A Comment